Preview Newsletter
XARELTO Media Monitoring – Week of 5-13-16
-
Xarelto Lawsuit Consolidation Completed By JPMDL
May 11, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on the immense number of cases being filed against Bayer AG and Johnson and Johnson Corporation subsidiary, Janssen Pharmaceuticals related to Xarelto, a blood-thinning drug, which has been alleged to have caused instances of uncontrolled and very dangerous bleeding in patients using it. Resulting from a large number of cases, a group of plaintiffs that had filed individual lawsuits petitioned the U.S. Judicial Panel on Multidistrict Litigation (JPMDL) in October 2015 to consider the consolidation of the cases since all of the 2,800 and more cases filed involved the same defendants and very similar allegations about the drug. -
Xarelto Lawsuit Alleges Drug Caused Uncontrollable Bleeding Death
May 11, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on serious safety concerns as well as numerous lawsuits that have been filed related to the use of Xarelto, a blood-thinning drug manufactured by Bayer AG and Janssen Pharmaceuticals, a subsidiary of the Johnson and Johnson Corporation. To date, more than 2,800 cases have been filed in federal courts across the nation claiming that the drug caused dangerous and often times fatal uncontrollable bleeding. -
Xarelto Lawsuit Plaintiff Claims Drug Caused Fathers Fatal Brain Bleed
May 11, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on a lawsuit (case number 2:14-cv-00159-CR) filed in the state of Vermont by the daughter of a deceased Xarelto user, her father, who she claims died from uncontrollable brain bleeding caused by his use of the drug when he sustained an injury. -
Xarelto Lawsuit Plaintiff Claims Mans Death Was Caused By Anticoagulant
May 11, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on Xarelto, a blood thinner drug used to treat atrial fibrillation, a heart condition that can at times put patients at a higher risk of blood clots or strokes. Many patients diagnosed with this heart issue take blood thinners as a proactive and preventative measure to help prevent such risks. Xarelto has also been alleged to sometimes cause uncontrollable bleeding. -
Texas Couple File Xarelto Lawsuit Alleging Internal Bleeding
May 12, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on Xarelto, a very popular blood thinner medication. When it was initially released it was unlike blood thinners before it, in that it allowed greater flexibility to the patient. Today, however, after 5 years on the market, the drug is immersed in controversy, with over 3,400 lawsuits filed by users who claimed the drug caused excessive and uncontrollable internal and external bleeding. The thousands of lawsuits that have been filed are all against the same defendants, Bayer Healthcare, and Janssen Pharmaceuticals, the manufacturers of the drug, and allege very similar experiences that focus on uncontrollable bleeding precipitated from its use and fatal in many cases. -
Xarelto Lawsuit Plaintiffs Claim Drug Caused Dangerous Internal Bleeding
May 12, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on plaintiff’s allegations in a Texas lawsuit filed against the manufacturers of Xarelto, Bayer Healthcare and Janssen Pharmaceuticals, a subsidiary of corporate giant Johnson and Johnson. The plaintiffs in this particular case are a couple, who claim that Bayer and Janssen failed to warn patients and medical professionals of the dangerous risks related to the use of Xarelto, a blood-thinning drug. -
Life-Threatening Internal Bleed Claimed By Xarelto Lawsuit Plaintiffs
May 12, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on Xarelto, a blood-thinning drug manufactured by Bayer Healthcare and Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson Corporation. Xarelto was a very popular blood-thinning drug when it first came out on the market 5 years ago but since then it has become ensnared in controversy, with more than 3,400 lawsuits being filed against Bayer and Janssen alleging the drug has caused uncontrollable and life-threatening internal and external bleeding. There have also been claims made that said manufacturers also did not adequately warn consumers and medical professionals about the possible dangers of the drug. -
Xarelto Lawsuit Plaintiffs Find Encouragement In Previous Pradaxa Settlement
May 13, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on striking similarities between Pradaxa and Xarelto lawsuits that provides encouragement to plaintiffs in numerous Xarelto lawsuits as they await their day in court. Pradaxa was released in 2010 by Boehringer Ingelheim and shortly after its availability on the market it was hit with over 3,500 adverse event reports with over 750 of them being fatalities. The volume of adverse reports filed against Pradaxa quickly made it the subject of over 4,000 lawsuits. The drug’s manufacturer, on the eve that the trials were to begin, settled all lawsuits with a $650 million settlement. Many Xarelto plaintiffs are hoping a similar result will ensue for them. -
Xarelto Lawsuit Plaintiff Claims Drug Caused Father's Fatal Brain Bleed
May 11, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on a lawsuit (case number 2:14-cv-00159-CR) filed in the state of Vermont by the daughter of a deceased Xarelto user, her father, who she claims died from uncontrollable brain bleeding caused by his use of the drug when he sustained an injury. -
Man Claims Xarelto Side Effect Led to Permanent Injury
May 6, 2016 | Top Class Actions
By Joanne Szabo
A Pennsylvania man’s Xarelto lawsuit alleges that he suffered from a serious Xarelto side effect, leading led to major complications and permanent injury, as a result of taking the popular blood thinner medication. -
Blood Thinner Patient Files Xarelto Side Effects Lawsuit
May 10, 2016 | Top Class Actions
By Paul Tassin
A man from Oklahoma is bringing a multi-million dollar claim against the manufacturers of his blood thinner medication, claiming they were responsible for his severe bleeding injury. -
Xarelto Bleeding Claims Continue, as Federal Litigation Surpasses 4,500 Filings
May 10, 2016 | Bernstein Liebhard LLP
Xarelto bleeding claims continue to mount in the federal multidistrict litigation now underway in the U.S. district Court, Eastern District of Louisiana. According to court documents, more than 4,500 cases were pending in the proceeding as of April 15, 2016. - See more at: http://www.consumerinjurylawyers.com/xarelto-bleeding-lawsuits-surpass-4500-cases-in-federal-court#sthash.gUifPSEk.dpuf -
Xarelto Lawsuit Alleges Blood Thinner Caused GI Bleed
May 12, 2016 | Top Class Actions
By Laura Schultz
A group of plaintiffs recently filed a new Xarelto lawsuit against the manufacturers and marketers of the popular blood thinning medication. -
Thousands of Xarelto Lawsuits Filed Alleging Injury, Death
May 12, 2016 | LawyersandSettlements.com
By Heidi Turner
Thousands of Xarelto lawsuits have been filed against the makers of the blood thinner, alleging patients suffered serious injuries or even death as a result of taking the anticoagulant. Among the alleged Xarelto side effects are an increased risk of uncontrolled bleeding, which can turn into a fatal bleeding event. In addition to Xarelto, the makers of other blood thinners also face allegations of failure to adequately warn about the risks associated with their drugs.
Client Attorney Privileged/Attorney Work Product/At Request of Counsel
Plaintiff Attorney Press Releases
Plaintiff Attorney Blog Posts
Full Text of Stories Below
-
Xarelto Lawsuit Consolidation Completed By JPMDL
May 11, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on the immense number of cases being filed against Bayer AG and Johnson and Johnson Corporation subsidiary, Janssen Pharmaceuticals related to Xarelto, a blood-thinning drug, which has been alleged to have caused instances of uncontrolled and very dangerous bleeding in patients using it. Resulting from a large number of cases, a group of plaintiffs that had filed individual lawsuits petitioned the U.S. Judicial Panel on Multidistrict Litigation (JPMDL) in October 2015 to consider the consolidation of the cases since all of the 2,800 and more cases filed involved the same defendants and very similar allegations about the drug.
The petitioners in the multidistrict consolidation litigation (MDL) asked that all the cases involved be under the jurisdiction of a court in the Southern District of Illinois. However, the defendants in the case argued against this move since they were located in New Jersey and felt it would be more prudent to have them assigned to a New Jersey court.
In a decision handed down on December 12, 2015, the judicial panel agreed with the petitioners and opted to consolidate and centralize all the bleeding cases involving Xarelto to the Honorable U.S. District Court Judge Eldon E. Fallon in the eastern District of Louisiana. The panel expressed its confidence in Judge Fallon to prudently and effectively oversee the consolidation since he was very experienced with MDL and was willing and able to do so.
The panel felt that having each case heard individually would only serve to increase the amount of time spent by those parties involved in the cases as well as the legal expenses that would be incurred. The panel also felt such a consolidation would reduce lengthy and sometimes very expensive discovery processes.
To request additional information on Xarelto bleeding lawsuits, or to ask questions at any time, contact Joseph Osborne, Esq. by calling (866) 425-8902.
http://www.cwrichmond.tv/story/31952913/xarelto-lawsuit-consolidation-completed-by-jpmdl
-
Xarelto Lawsuit Alleges Drug Caused Uncontrollable Bleeding Death
May 11, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on serious safety concerns as well as numerous lawsuits that have been filed related to the use of Xarelto, a blood-thinning drug manufactured by Bayer AG and Janssen Pharmaceuticals, a subsidiary of the Johnson and Johnson Corporation. To date, more than 2,800 cases have been filed in federal courts across the nation claiming that the drug caused dangerous and often times fatal uncontrollable bleeding. Since there have been so many lawsuits filed against the manufacturers for the same reason, these cases have been consolidated in a multidistrict litigation (MDL), numbered MDL 2592. In addition to the MDL, a tort litigation group has been formed in Philadelphia, PA combining more than 550 more Xarelto lawsuits together.
Xarelto is approved for and can be prescribed to treat atrial fibrillation, that can, at times, cause blood clots or stroke. Blood thinners are prescribed as a preventative measure in these types of medical situations to prevent such serious occurrences.
In one particular case, the plaintiff has filed a lawsuit in a Vermont federal courtroom (number 2:14-cv-00159-CR) on behalf of her father, who she claims in her court documents, died as a result of excessive bleeding in his brain which doctors could not get to clot due to his use of Xarelto.
Other blood thinners, such as warfarin, were released on the market with an antidote such as Vitamin K, that would counteract this class of blood thinner and thus allow the patient to form blood clots to stop the bleeding. Xarelto, on the other hand, did not have any such antidote at the time of its release on the market. The only recourse was for doctors to resort to life-threatening surgical procedures or transfusions of blood.
The plaintiff in the Vermont case states that the drug’s manufacturers were negligent in knowingly releasing a drug with no known antidote that could cause uncontrollable fatal bleeding.
To request more information on Xarelto lawsuits, or ask questions, contact Joseph Osborne, Esq. by calling (866) 425-8902.
http://www.cwrichmond.tv/story/31952910/xarelto-lawsuit-alleges-drug-caused-uncontrollable-bleeding-death
-
Xarelto Lawsuit Plaintiff Claims Drug Caused Fathers Fatal Brain Bleed
May 11, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on a lawsuit (case number2:14-cv-00159-CR) filed in the state of Vermont by the daughter of a deceased Xarelto user, her father, who she claims died from uncontrollable brain bleeding caused by his use of the drug when he sustained an injury.
In her lawsuit paperwork, she claims her father was prescribed Xarelto to treat his atrial fibrillation, a heart condition that can sometimes put patients at risk for blood clots or stroke. Blood thinners, such as Xarelto, are used as a proactive and preventative option to prevent clotting or stroke. Her lawsuit has been filed against the makers of the drug, Bayer AG and Janssen Pharmaceuticals, a subsidiary of the Johnson and Johnson Corporation.
She further states in her court filing, that her father had only been using Xarelto for a brief period. After his fall and the brain bleeding occurred, he was diagnosed with a parenchymal hemorrhage, which is a kind of intracerebral hemorrhage. He eventually died from the bleeding.
Many blood thinners, such as warfarin, are accompanied with an antidote via the use of Vitamin K, which acts to counter the effects of the blood thinner and allows blood to form clots. At the time of the plaintiff’s father’s death, there was no antidote released with Xarelto, leaving doctors with no option other than blood transfusions or surgery.
The plaintiff is claiming that the drug’s manufacturers were negligent in releasing a drug on the market with no known antidote, which can create potentially lethal bleeding dangers, as was the case with her father.
In addition to the plaintiff’s lawsuit, many others have been filed claiming the drug caused uncontrollable bleeding. 550 lawsuits have been consolidated into a group tort litigation in Philadelphia, PA, along with 2,800 others that have been grouped together in a Multidistrict Litigation (MDL) numbered 2592.
The Osborne firm is offering free consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. Call (866) 425-8902 for more information about this release or the Xarelto litigation.
http://www.kxxv.com/story/31952905/xarelto-lawsuit-plaintiff-claims-drug-caused-fathers-fatal-brain-bleed
-
Xarelto Lawsuit Plaintiff Claims Mans Death Was Caused By Anticoagulant
May 11, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on Xarelto, a blood thinner drug used to treat atrial fibrillation, a heart condition that can at times put patients at a higher risk of blood clots or strokes. Many patients diagnosed with this heart issue take blood thinners as a proactive and preventative measure to help prevent such risks. Xarelto has also been alleged to sometimes cause uncontrollable bleeding.
One issue with Xarelto is that the drug was released without an antidote to prevent possible uncontrollable bleeding. Most traditional blood thinner drugs, such as warfarin, utilize an antidote of Vitamin K if excessive bleeding were to occur. Vitamin K acts as a clotting agent to counteract the effects of the blood thinner.
This issue is one of the main points alleged in a lawsuit (case number 2:14-cv-00159-CR) in Vermont filed by the daughter on behalf of her father, who unfortunately died due to excessive and uncontrollable bleeding from an unexpected injury resulting in a brain bleed that doctors diagnosed as parenchymal hemorrhage, a type of intracerebral hemorrhage. Doctors were only able to keep him alive for 6 days before he died. Even though her father had only taken the drug for a minimal time, she is stating in her paperwork that her father died as a result of taking Xarelto. The lawsuit has been filed against the makers of the drug, Bayer AG and Janssen Pharmaceuticals, a subsidiary company of corporate giant Johnson and Johnson.
Unfortunately, the Vermont plaintiff is not alone in filing a lawsuit related to uncontrollable bleeding alleged to have been caused by Xarelto. In Philadelphia, PA, 550 cases have been grouped together in a mass tort program. Another 2,800 federally-filed cases have been consolidated into Multidistrict Litigation (MDL) 2592.
The Osborne firm is offering free consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. Call (866) 425-8902 for more information about this release or the Xarelto litigation.
http://www.wrcbtv.com/story/31942322/xarelto-lawsuit-plaintiff-claims-mans-death-was-caused-by-anticoagulant
-
Texas Couple File Xarelto Lawsuit Alleging Internal Bleeding
May 12, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on Xarelto, a very popular blood thinner medication. When it was initially released it was unlike blood thinners before it, in that it allowed greater flexibility to the patient. Today, however, after 5 years on the market, the drug is immersed in controversy, with over 3,400 lawsuits filed by users who claimed the drug caused excessive and uncontrollable internal and external bleeding. The thousands of lawsuits that have been filed are all against the same defendants, Bayer Healthcare, and Janssen Pharmaceuticals, the manufacturers of the drug, and allege very similar experiences that focus on uncontrollable bleeding precipitated from its use and fatal in many cases.
One lawsuit, in particular, filed by a couple in Texas in the Eastern District of New York, whose case (filed under case number 1:14-cv-04524) is now part of the consolidated multidistrict litigation (MDL) number 2592 in Louisiana, that was approved by the U.S. Judicial Panel for Multidistrict Litigation (JPMDL) focuses on the failure of the manufacturers of Xarelto, to sufficiently warn patients of the potential risks associated with taking the drug.
The female complainant, in this case, was prescribed Xarelto by her doctor because she was at an increased risk of and susceptible to having a stroke because of her atrial fibrillation. She claims that only after 5 months of taking the drug for her heart condition she experienced a very quick onset of internal bleeding. She also states that because of the bleeding it has left her with some serious long-term health issues as well.
It should also be noted the number of new complaints and court filings has increased while those plaintiffs involved in the 3,400 already filed cases await their day in court to pursue justice for themselves and those who have died from excessive bleeding allegedly because of using Xarelto.
The Osborne firm is offering free consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. Call (866) 425-8902 for more information about this release or the Xarelto litigation.
http://www.newschannel10.com/story/31958155/texas-couple-file-xarelto-lawsuit-alleging-internal-bleeding
-
Xarelto Lawsuit Plaintiffs Claim Drug Caused Dangerous Internal Bleeding
May 12, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on plaintiff’s allegations in a Texas lawsuit filed against the manufacturers of Xarelto, Bayer Healthcare and Janssen Pharmaceuticals, a subsidiary of corporate giant Johnson and Johnson. The plaintiffs in this particular case are a couple, who claim that Bayer and Janssen failed to warn patients and medical professionals of the dangerous risks related to the use of Xarelto, a blood-thinning drug.
Xarelto has been on the market for approximately 5 years and was very popular with patients since they had much more freedom and flexibility with this drug than with blood thinners used before its release. Today, however, the drug is immersed in controversy, with over 3,400 lawsuits having been filed grounded in very similar allegations that it increased the risk for dangerous and uncontrollable bleeding in patients both internally and externally.
The female plaintiff in this particular case alleges to have been prescribed Xarelto as a treatment for her atrial fibrillation and to minimize the risk of stroke which she was deemed to be more susceptible to due to that medical condition related to her heart. She alleges that she had only used the drug for 5 months when she experienced a very sudden onset of life-threatening internal bleeding that has left her struggling with long-term medical issues.
This lawsuit initiated by the Texas couple was initially filed in the Eastern District of New York under case number 1:14-cv-04524. However, since the decision made by the U.S. Judicial Panel for Multidistrict Litigation (JPMDL) to consolidate cases in Eastern Louisiana was handed down, this case was transferred to that multidistrict litigation (MDL) and was assigned number MDL 2592. Complaints against the drug continue to increase while the numerous plaintiffs involved in this MDL await their day in court.
The Osborne firm is offering free consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. Call (866) 425-8902 for more information about this release or the Xarelto litigation.
http://www.12newsnow.com/story/31963283/xarelto-lawsuit-plaintiffs-claim-drug-caused-dangerous-internal-bleeding
-
Life-Threatening Internal Bleed Claimed By Xarelto Lawsuit Plaintiffs
May 12, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on Xarelto, a blood-thinning drug manufactured by Bayer Healthcare and JanssenPharmaceuticals, a subsidiary of Johnson and Johnson Corporation. Xarelto was a very popular blood-thinning drug when it first came out on the market 5 years ago but since then it has become ensnared in controversy, with more than 3,400 lawsuits being filed against Bayer and Janssen alleging the drug has caused uncontrollable and life-threatening internal and external bleeding. There have also been claims made that said manufacturers also did not adequately warn consumers and medical professionals about the possible dangers of the drug.
One such case has been filed by a Texas couple. The female plaintiff, in this case, suffered from atrial fibrillation, a medical condition adversely impacting the heart. Atrial fibrillation can potentially increase the risk of strokes in patients and blood-thinning medications are often prescribed as a proactive and preventative measure to avoid that risk. Xarelto was prescribed to the plaintiff to help prevent any chance of a stroke happening.
After only 5 months of taking Xarelto, the plaintiff claims that she suffered a life-threatening episode of spontaneous internal bleeding. She also claims that because of that bleeding, she now deals with long-term medical issues to this day.
It should be noted that this particular lawsuit was filed by the Texas couple in a court in the Eastern District of New York. However, due to the consolidation of the multitude of cases by the U.S. Judicial Panel on Multidistrict Litigation (JPMDL) against Xarelto because of strikingly similar allegations about the drug, the case was transferred to Eastern Louisiana as part of the consolidated multidistrict litigation (MDL) 2592.
The Osborne firm is offering free consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. Call (866) 425-8902 for more information about this release or the Xarelto litigation.
http://www.kiiitv.com/story/31963454/life-threatening-internal-bleed-claimed-by-xarelto-lawsuit-plaintiffs
-
Xarelto Lawsuit Plaintiffs Find Encouragement In Previous Pradaxa Settlement
May 13, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on striking similarities between Pradaxa and Xarelto lawsuits that provides encouragement to plaintiffs in numerous Xarelto lawsuits as they await their day in court. Pradaxa was released in 2010 by Boehringer Ingelheim and shortly after its availability on the market it was hit with over 3,500 adverse event reports with over 750 of them being fatalities. The volume of adverse reports filed against Pradaxa quickly made it the subject of over 4,000 lawsuits. The drug’s manufacturer, on the eve that the trials were to begin, settled all lawsuits with a $650 million settlement. Many Xarelto plaintiffs are hoping a similar result will ensue for them.
There have been over 2,800 federally-filed complaints against Xarelto. Due to the magnitude of the complaints and similarities of the allegations against the drug’s manufacturers, Bayer AG and Janssen Pharmaceuticals, a subsidiary company of Johnson and Johnson Corporation, the United States Judicial Panel on Multidistrict Litigation (JPMDL) consolidated all cases to be heard together in a multidistrict litigation (MDL). Since the consolidation and in the month of August 2015 alone, the MDL expanded by 400 more cases and that number is expected to increase even further as Xarelto lawsuits continue to grow in both Louisiana and Pennsylvania.
The MDL is being overseen by the Honorable Judge Eldon Fallon in the Eastern District of Louisiana. The cases encompassed in the MDL are inching toward litigation. He had set a January 11, 2016, deadline for having 40 bellwether cases in a pool from which 4 would be selected for initial trials beginning in the spring of 2017.
It should also be noted that the 2,800 cases in the MDL are not the only ones being litigated. There is another group of 550 cases that have been consolidated in the Court of Common Pleas in Philadelphia, PA. The defendants in all these cases are Bayer and Janssen, as well.
The Osborne firm is offering free consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. Call (866) 425-8902 for more information about this release or the Xarelto litigation.
http://www.ktvn.com/story/31967134/xarelto-lawsuit-plaintiffs-find-encouragement-in-previous-pradaxa-settlement
-
Xarelto Lawsuit Plaintiff Claims Drug Caused Father's Fatal Brain Bleed
May 11, 2016 | Bloodthinnerhelp.com
By Joseph Osborne
BloodThinnerHelp.com reports on a lawsuit (case number 2:14-cv-00159-CR) filed in the state of Vermont by the daughter of a deceased Xarelto user, her father, who she claims died from uncontrollable brain bleeding caused by his use of the drug when he sustained an injury.
In her lawsuit paperwork, she claims her father was prescribed Xarelto to treat his atrial fibrillation, a heart condition that can sometimes put patients at risk for blood clots or stroke. Blood thinners, such as Xarelto, are used as a proactive and preventative option to prevent clotting or stroke. Her lawsuit has been filed against the makers of the drug, Bayer AG and Janssen Pharmaceuticals, a subsidiary of the Johnson and Johnson Corporation.
She further states in her court filing, that her father had only been using Xarelto for a brief period. After his fall and the brain bleeding occurred, he was diagnosed with a parenchymal hemorrhage, which is a kind of intracerebral hemorrhage. He eventually died from the bleeding.
Many blood thinners, such as warfarin, are accompanied with an antidote via the use of Vitamin K, which acts to counter the effects of the blood thinner and allows blood to form clots. At the time of the plaintiff's father's death, there was no antidote released with Xarelto, leaving doctors with no option other than blood transfusions or surgery.
The plaintiff is claiming that the drug's manufacturers were negligent in releasing a drug on the market with no known antidote, which can create potentially lethal bleeding dangers, as was the case with her father.
In addition to the plaintiff's lawsuit, many others have been filed claiming the drug caused uncontrollable bleeding. 550 lawsuits have been consolidated into a group tort litigation in Philadelphia, PA, along with 2,800 others that have been grouped together in a Multidistrict Litigation (MDL) numbered 2592.
The Osborne firm is offering free consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. Call (866) 425-8902 for more information about this release or the Xarelto litigation.
https://www.pressadvantage.com/story/9863-xarelto-lawsuit-plaintiff-claims-drug-caused-father-s-fatal-brain-bleed
-
Man Claims Xarelto Side Effect Led to Permanent Injury
May 6, 2016 | Top Class Actions
By Joanne Szabo
A Pennsylvania man’s Xarelto lawsuit alleges that he suffered from a serious Xarelto side effect, leading led to major complications and permanent injury, as a result of taking the popular blood thinner medication.
The plaintiff, David B., filed his Xarelto side effect lawsuit against Janssen Pharmaceuticals and several other defendants. The lawsuit brings complaints including fraud, design defect, failure to warn, and negligent representation.
David alleges in his Xarelto lawsuit that he began taking the blood clot treatment on February 7, 2014, after discussing his options with his physician. On April 8, 2014, David began experiencing gastrointestinal bleeding, rectal bleeding, and anemia. These severe Xarelto side effects required David to be hospitalized.
In addition to the painful physical injury, David alleges that he suffered from mental anguish as well.
David’s Xarelto lawsuit alleges that Janssen and the other defendants failed to properly investigate and test the safety of Xarelto. His lawsuit also claims that the defendants failed to provide adequate warnings to the public and the medical community that there is no effective antidote available to reverse the serious bleeding that may happen when taking Xarelto.
What is Xarelto?
Xarelto (generic name rivaroxaban) has been targeted in a rising number of Xarelto lawsuits against Janssen Pharmaceuticals. Janssen is a subsidiary of the pharmaceutical giant Johnson & Johnson.
Xarelto is a blood thinner used to prevent dangerous blood clotting. Blood clot treatment is often necessary for patients who suffer from atrial fibrillation (irregular heartbeat), pulmonary embolism (blood clots in the lungs), or deep vein thrombosis (blood clots deep inside the patient’s body).
While most Xarelto side effects are mild, a number of studies and lawsuits have linked the medication with a risk of severe bleeding.
Many Xarelto lawsuits claim that the manufacturer knew of these risks, yet continued to market the blood clot treatment as if it were safe and effective, diminishing or dismissing any concern over the possibility of a severe Xarelto side effect.
Filing a Xarelto Side Effect Lawsuit
Although filing a lawsuit cannot take away the pain of a patient suffering from a severe Xarelto side effect, a lawsuit can help to alleviate the financial problems brought on by medical bills and lost wages that can occur.
If you or someone you love has suffered from a serious Xarelto side effect such as excessive internal bleeding after using Xarelto, you may be able to file a Xarelto lawsuit against Janssen Pharmaceuticals.
https://topclassactions.com/lawsuit-settlements/lawsuit-news/334396-pennsylvania-man-claims-xarelto-side-effect-led-permanent-injury/
-
Blood Thinner Patient Files Xarelto Side Effects Lawsuit
May 10, 2016 | Top Class Actions
By Paul Tassin
A man from Oklahoma is bringing a multi-million dollar claim against the manufacturers of his blood thinner medication, claiming they were responsible for his severe bleeding injury.
Plaintiff George B. says he suffered life-threatening bleeding and related consequences as a result of the defendants’ mishandling of their knowledge of Xarelto’s dangerous side effects.
George says he had been taking Xarelto for just a few months, from March to May 2014, when he suffered a hemorrhage in his right renal capsule. He attributes that Xarelto bleeding injury to the medication he had been taking.
George is bringing this Xarelto lawsuit against Janssen Pharmaceuticals, Bayer Healthcare Pharmaceuticals and their related companies, all of whom he alleges had a hand in designing, manufacturing or selling Xarelto.
Xarelto is a new-generation blood thinner approved by the FDA to help prevent blood clot-related injuries like stroke in persons with non-valvular atrial fibrillation. It’s also approved as a treatment for deep vein thrombosis and pulmonary embolism, and as a means to prevent those conditions from recurring.
Studies Show Risks of Blood Thinner Treatment
George cites a few clinical studies that he believes should have put the manufacturers on notice about the risk of Xarelto bleeding. One group of studies known as the RECORD studies compared Xarelto, referred to in the studies by its generic name rivaroxaban, to another blood thinner named enoxaparin. The studies found Xarelto bleeding led more often to decreased hemoglobin levels and need for blood transfusion, George says.
Another study called the ROCKET AF study compared Xarelto to the anticoagulant warfarin. George says that findings in that study showed that Xarelto was associated with more frequent bleeding from gastrointestinal sites, in addition to bleeding requiring transfusion or causing a drop in hemoglobin.
Yet another study, the EINSTEIN-PE study, demonstrated an increased risk of adverse events associated with Xarelto, including events that required prolonged hospitalization or permanent discontinuation of Xarelto.
George is making claims against Janssen and Bayer based on theories of negligence, products liability, breach of warranty, misrepresentation, concealment of vital information, and fraud. He alleges that due to the defendant’s actions he has been harmed to the tune of $10 million.
The Xarelto MDL
George’s Xarelto lawsuit is one of 2,800 similar claims that have been brought together in a single court as a multidistrict litigation, or MDL. The Xarelto MDL is going on in federal court in New Orleans, under the supervision of U.S. District Judge Eldon Fallon.
Generally, the plaintiffs in these cases make allegations similar to George’s. They typically say that Janssen and Bayer failed to properly warn Xarelto users about the risks of blood thinner side effects, and that if they had been properly informed they may have elected not to take Xarelto.
The first few cases in the MDL to go to trial, known as “bellwether” trials, are scheduled to begin in early 2017. These four cases will be selected from a pool of forty consisting of ten cases selected by each side plus twenty cases randomly selected by the court.
More Xarelto lawsuits may join the MDL by the time the bellwether trials begin.
The Xarelto lawsuit is George B. v Janssen, part of the pending Xarelto MDL, MDL No. 2592 in the U.S. District Court for the Eastern District of Louisiana.
https://topclassactions.com/lawsuit-settlements/lawsuit-news/334647-blood-thinner-patient-claims-10m-damages/
-
Xarelto Bleeding Claims Continue, as Federal Litigation Surpasses 4,500 Filings
May 10, 2016 | Bernstein Liebhard LLP
Xarelto bleeding claims continue to mount in the federal multidistrict litigation now underway in the U.S. district Court, Eastern District of Louisiana. According to court documents, more than 4,500 cases were pending in the proceeding as of April 15, 2016.
One of the most recent Xarelto lawsuits was filed on behalf of an Ohio man who allegedly died from serious internal bleeding less than a year after he was prescribed the blood-thinning medication. His family is seeking compensation for his alleged wrongful death, as well as fraud, breach of warranty, design defect, failure to warn, and negligent misrepresentation.
According to the April 8th complaint, the Decedent began taking Xarelto in December 2013, and continued using the drug until August 2014. On April 9, 2014, he suffered gastrointestinal bleeding that his family claims was the direct and proximate result of his Xarelto use. (Case No. 2:16-cv-02913)Allegations Put Forth by Xarelto Plaintiffs
Xarelto was approved by the U.S. Food & Drug Administration (FDA) in 2011. It is currently indicated for the prevention of strokes in people with atrial fibrillation; the treatment of deep vein thrombosis and pulmonary embolism; and the prevention of deep vein thrombosis in patients undergoing hip or knee replacement surgery. Like any blood thinner, Xarelto can sometimes cause internal bleeding. However, there is currently no approved antidote for reversing this potentially deadly complication. By contrast, bleeding associated with a much older blood thinner called warfarin can be stopped via the administration of Vitamin K.
All of the Xarelto lawsuits now pending in the Eastern District of Louisiana claim that the drug’s manufacturers failed to provide adequate warnings regarding uncontrollable internal bleeding and other serious side effects, including strokes, deep vein thrombosis and pulmonary embolism, allegedly associated with its use. Plaintiffs also assert that the drug makers wrongly promoted Xarelto as a superior alternative to warfarin, considering its lack of a reversal agent for internal bleeding.
The Xarelto litigation is scheduled to convene a series of bellwether trials beginning in February 2017. These trials will be closely watched by other plaintiffs, as the outcomes in the cases could provide valuable insight into jury decisions in similar Xarelto lawsuits.
Bernstein Liebhard LLP is currently representing clients in Xarelto bleeding claims. If you are interested in filing a similar lawsuit, please contact our office by calling 877-779-1414.
- See more at: http://www.consumerinjurylawyers.com/xarelto-bleeding-lawsuits-surpass-4500-cases-in-federal-court#sthash.gUifPSEk.dpuf
http://www.consumerinjurylawyers.com/xarelto-bleeding-lawsuits-surpass-4500-cases-in-federal-court
-
Xarelto Lawsuit Alleges Blood Thinner Caused GI Bleed
May 12, 2016 | Top Class Actions
By Laura Schultz
A group of plaintiffs recently filed a new Xarelto lawsuit against the manufacturers and marketers of the popular blood thinning medication.
The Xarelto lawsuit alleges that the pharmaceutical manufacturer violated consumer protection laws and caused several consumers to suffer from internal bleeding, pulmonary hemorrhage, and even wrongful death.
The Xarelto lawsuit was filed by James B. and several others individually and on behalf of patients who are now deceased. The lawsuit names as defendants Janssen Research and Development, Johnson & Johnson Pharmaceuticals, and Bayer Pharmaceuticals.
According to the lawsuit, James took Xarelto between November 2013 and January 2015. James alleges that he suffered from severe anemia, gastrointestinal bleeding, and hematuria in November of 2013 and January of 2015. Although James survived the adverse side effects he experienced from taking Xarelto, several of the others involved in the lawsuit passed away due to alleged Xarelto side effects.
One of the unfortunate patients was Joann B. According to the Xarelto lawsuit, Joann began taking Xarelto in January of 2011 and continued taking the medication until she died of a pulmonary hemorrhage in May of 2013. The Xarelto lawsuit alleges that Joann died due to injuries she suffered as a result of taking Xarelto.
What is Xarelto?
Xarelto, generically known as rivaroxaban, is a popular anticoagulant often prescribed by medical professionals to help prevent blood clots from forming after surgery. Patients have also been prescribed Xarelto to help lower the risk of stroke and clots after being diagnosed with atrial fibrillation.
Xarelto belongs to a family of blood thinners that works in a different way than older blood thinning medications. It works by preventing the formation of thrombin, which is an essential component of blood clotting. Xarelto is often advertised as a superior alternative to more traditional blood thinners like Warfarin, because Xarelto does not require the patient to follow a strict diet or undergo constant blood monitoring.
Unfortunately, unlike Warfarin, patients taking Xarelto do not have an FDA-approved antidote available to counteract the anticoagulant effect of the medication.
Internal bleeding and uncontrolled bleeding are a side effect of all blood thinning medications, but without an antidote to counteract the bleeding effects, adverse side effects can be even more dangerous and potentially fatal.
Xarelto Side Effects Lawsuits
Several adverse side effects including internal bleeding and pulmonary hemorrhage have been linked to taking Xarelto. Injured patients and loved ones have filed lawsuits against the pharmaceutical manufacturer alleging that the company failed to disclose the increased risks of developing these side effects in comparison to other more traditional blood thinners.
Patients who have experienced any of these adverse side effects while taking Xarelto may be able to bring a lawsuit against the manufacturer. Family members who have lost loved ones to the side effects may be eligible to bring a wrongful death lawsuit.
The Xarelto lawsuit referenced above is MDL No. 2592, filed in the United States District Court in the Eastern District of Louisiana.
-
Thousands of Xarelto Lawsuits Filed Alleging Injury, Death
May 12, 2016 | LawyersandSettlements.com
By Heidi Turner
Thousands of Xarelto lawsuits have been filed against the makers of the blood thinner, alleging patients suffered serious injuries or even death as a result of taking the anticoagulant. Among the alleged Xarelto side effects are an increased risk of uncontrolled bleeding, which can turn into a fatal bleeding event. In addition to Xarelto, the makers of other blood thinners also face allegations of failure to adequately warn about the risks associated with their drugs.
According to court documents, one such lawsuit was filed in February by a woman who alleges she suffered serious side effects from using Xarelto. The plaintiff, Margaret Garvy, argues she only used Xarelto from May 8, 2014 to May 18, 2014 - 10 days. On May 18, she allegedly suffered hemorrhagic pericardial effusion, pericardial tamponade and plural effusion, requiring hospitalization and medical treatment and resulting in permanent injuries.
The lawsuit alleges patients were not adequately warned about the risks associated with Xarelto, but Garvy’s lawsuit further alleges the trials on which Xarelto was approved - the RECORD studies - were “flawed in design and conducted in a negligent manner.”
“In fact, FDA Official Action Indicated (‘OAI’) - rated inspections in 2009 disclosed rampant violations including, ‘systemic discarding of medical records,’ unauthorized unblinding, falsification, and ‘concerns regarding improprieties in randomization,’” the lawsuit claims. “As a result, the FDA found that the RECORD 4 studies were so flawed that they were deemed unreliable.”
Despite concerns about the RECORD trial, Xarelto was approved for use, partially based on a trial known as the ROCKET AF trial. That trial showed Xarelto was at least as good as warfarin in preventing stroke or systemic embolism in patients with non-valvular atrial fibrillation, according to the lawsuit. But Garvy alleges the study participants who received warfarin were not well managed, and as a result, Xarelto appeared to be non-inferior to warfarin, when the two groups could not have been adequately compared.“The warfarin group in the ROCKET AF study was the worst managed warfarin study group in any previously reported clinical trial involving warfarin,” Garvy’s lawsuit alleges.
Of concern is that Xarelto was reportedly marketed as not requiring blood monitoring - which ensures patient’s blood plasma levels stay within certain guidelines - but critics and some patients say Xarelto is still safer if patients receive regular monitoring and dose adjustments.
As of April 15, 2015, there were 4,579 lawsuits consolidated for pretrial proceedings in MDL 2592 before US District Judge Eldon E. Fallon.
The Garvy lawsuit is Garvy v. Janssen Research & Development, et al., Case number 2:16-cv-01359, US District Court, Eastern District of Louisiana.https://www.lawyersandsettlements.com/articles/xarelto/xarelto-lawsuit-death-bleeding-issue-41-21470.html
Client Attorney Privileged/Attorney Work Product/At Request of Counsel
Plaintiff Attorney Press Releases
Plaintiff Attorney Blog Posts
Full Text of Stories Below
Add recipients
Suggested